These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17950993)

  • 1. Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7.
    Kim HJ; Kim JB; Lee KM; Shin I; Han W; Ko E; Bae JY; Noh DY
    Cancer Lett; 2007 Dec; 258(1):98-108. PubMed ID: 17950993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
    Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
    Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening of a sub-clone of human breast cancer cells with high metastasis potential].
    Ye LH; Wu LY; Guo W; Ma HT; Zhang XD
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):61-5. PubMed ID: 16606541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential killing of breast tumor initiating cells by N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine/tesmilifene.
    Deng T; Liu JC; Pritchard KI; Eisen A; Zacksenhaus E
    Clin Cancer Res; 2009 Jan; 15(1):119-30. PubMed ID: 19118039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD24 expression is specific for tamoxifen-resistant ductal breast cancer cases.
    Surowiak P; Materna V; Paluchowski P; Matkowski R; Wojnar A; Maciejczyk A; Pudelko M; Kornafel J; Dietel M; Kristiansen G; Lage H; Zabel M
    Anticancer Res; 2006; 26(1B):629-34. PubMed ID: 16739331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24-/lower phenotype metastasis to human bone.
    Ling LJ; Wang S; Liu XA; Shen EC; Ding Q; Lu C; Xu J; Cao QH; Zhu HQ; Wang F
    Chin Med J (Engl); 2008 Oct; 121(20):1980-6. PubMed ID: 19080260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CD24 for treatment of ovarian cancer by short hairpin RNA.
    Su D; Deng H; Zhao X; Zhang X; Chen L; Chen X; Li Z; Bai Y; Wang Y; Zhong Q; Yi T; Qian Z; Wei Y
    Cytotherapy; 2009; 11(5):642-52. PubMed ID: 19593703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CD24 inhibits invasive growth, facilitates apoptosis and enhances chemosensitivity in gastric cancer AGS cells.
    Jiao XL; Zhao C; Niu M; Chen D
    Eur Rev Med Pharmacol Sci; 2013 Jul; 17(13):1709-15. PubMed ID: 23852892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis.
    Baumann P; Cremers N; Kroese F; Orend G; Chiquet-Ehrismann R; Uede T; Yagita H; Sleeman JP
    Cancer Res; 2005 Dec; 65(23):10783-93. PubMed ID: 16322224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of CD44+/CD24-/low breast cancer stem/progenitor cells to tamoxifen‑ and doxorubicin‑induced autophagy.
    Yenigun VB; Ozpolat B; Kose GT
    Int J Mol Med; 2013 Jun; 31(6):1477-83. PubMed ID: 23589132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-diabetic drug metformin suppresses the metastasis-associated protein CD24 in MDA-MB-468 triple-negative breast cancer cells.
    Vazquez-Martin A; Oliveras-Ferraros C; Cufí S; Del Barco S; Martin-Castillo B; Lopez-Bonet E; Menendez JA
    Oncol Rep; 2011 Jan; 25(1):135-40. PubMed ID: 21109968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue-specific promoters active in CD44+CD24-/low breast cancer cells.
    Bauerschmitz GJ; Ranki T; Kangasniemi L; Ribacka C; Eriksson M; Porten M; Herrmann I; Ristimäki A; Virkkunen P; Tarkkanen M; Hakkarainen T; Kanerva A; Rein D; Pesonen S; Hemminki A
    Cancer Res; 2008 Jul; 68(14):5533-9. PubMed ID: 18632604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction.
    Liu XH; Zheng XF; Wang YL
    Chin Med J (Engl); 2009 Jul; 122(14):1681-5. PubMed ID: 19719971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate.
    Raffo D; Berardi DE; Pontiggia O; Todaro L; de Kier Joffé EB; Simian M
    Breast Cancer Res Treat; 2013 Dec; 142(3):537-48. PubMed ID: 24258256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antrodia camphorata inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Hseu YC; Chen SC; Chen HC; Liao JW; Yang HL
    Food Chem Toxicol; 2008 Aug; 46(8):2680-8. PubMed ID: 18550246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of CD24 inhibits proliferation, invasion and sensitizes breast cancer MCF-7 cells to tamoxifen in vitro.
    Ma ZL; Chen YP; Song JL; Wang YQ
    Eur Rev Med Pharmacol Sci; 2015 Jul; 19(13):2394-9. PubMed ID: 26214774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
    Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.
    Mylona E; Giannopoulou I; Fasomytakis E; Nomikos A; Magkou C; Bakarakos P; Nakopoulou L
    Hum Pathol; 2008 Jul; 39(7):1096-102. PubMed ID: 18495204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.
    Ishii Y; Waxman S; Germain D
    Cancer Res; 2008 Feb; 68(3):852-60. PubMed ID: 18245487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.